How safe is safe, and where are we in the journey toward safest of safe?
作者信息
Dar Lalit, Tandon Radhika
机构信息
Professor In-charge Virology Section, Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Ophthalmol. 2017 Nov;65(11):1075-1076. doi: 10.4103/ijo.IJO_1054_17.
Abstract
摘要
相似文献
1
How safe is safe, and where are we in the journey toward safest of safe?怎样才算安全，在迈向绝对安全的道路上我们处于什么阶段？
Indian J Ophthalmol. 2017 Nov;65(11):1075-1076. doi: 10.4103/ijo.IJO_1054_17.
2
[Eye banks and available transplants].[眼库与可用移植]
Tidsskr Nor Laegeforen. 2008 Apr 17;128(8):929-32.
3
What is eye banking?什么是眼库？
Indian J Ophthalmol. 1996 Mar;44(1):1-2.
4
Donor corneal tissue evaluation.供体角膜组织评估。
Indian J Ophthalmol. 1996 Mar;44(1):3-13.
5
Use of eye bank sclera in plastic and reconstructive surgery.
J Med Assoc Ga. 1980 Feb;69(2):118-9.
6
Regulation of eye banking and uses of ocular tissue for transplantation.眼库的管理及眼组织在移植中的应用。
Clin Lab Med. 2005 Sep;25(3):607-24. doi: 10.1016/j.cll.2005.06.001.
7
[Indications and practical use of silica-dried material in ophthalmology].
Bull Soc Ophtalmol Fr. 1973 Sep-Oct;73(9-10):887-91.
8
[Eye banks].
Gac Med Mex. 1994 Jul-Aug;130(4):278.
9
Pneumococcal endophthalmitis following grafting of corneal tissue from a (cadaver) kidney donor.
Ann Ophthalmol. 1977 Apr;9(4):435-40.
10
The continuing evolution of medical standards in modern eye banking.
Cornea. 1994 Jul;13(4):289. doi: 10.1097/00003226-199407000-00001.
本文引用的文献
1
HCV RNA Testing of Plasma Samples from Cornea Donors: Suitability of Plasma Samples Stored at 4 °C for up to 8 Days.角膜供体血浆样本的丙型肝炎病毒RNA检测：4℃保存长达8天的血浆样本的适用性
Transfus Med Hemother. 2017 Jan;44(1):39-44. doi: 10.1159/000449207. Epub 2016 Nov 4.
2
Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India.印度北部一家医院血库中献血者感染标志物的血清流行率及其趋势
Indian J Med Res. 2015 Sep;142(3):317-22. doi: 10.4103/0971-5916.166598.
3
Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples.利用死后血液样本对 HIV、HCV、HBV 和 HAV 的病毒 NAT 进行验证。
Transfus Med Hemother. 2012 Dec;39(6):381-5. doi: 10.1159/000345319. Epub 2012 Nov 13.
4
Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients - First Results.尸检后 48 小时以上的感染患者死后血液标本中 HIV、HBV 和 HCV 的病毒 NAT - 初步结果。
Transfus Med Hemother. 2012 Dec;39(6):376-80. doi: 10.1159/000345610. Epub 2012 Nov 19.
5
Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors.角膜捐献者生前和死后血样的比较感染性血清学检测。
Cell Tissue Bank. 2012 Aug;13(3):447-52. doi: 10.1007/s10561-012-9326-0. Epub 2012 Jul 17.
6
Human immunodeficiency virus p24 antigen testing in cornea donors.角膜捐献者中的人类免疫缺陷病毒p24抗原检测
Cornea. 2001 Apr;20(3):277-80. doi: 10.1097/00003226-200104000-00008.
7
Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation.用于角膜移植供体选择的尸体血清学筛查评估。
J Med Virol. 1999 Jul;58(3):291-5. doi: 10.1002/(sici)1096-9071(199907)58:3<291::aid-jmv16>3.0.co;2-d.
8
Serologic testing of cornea donors.角膜供体的血清学检测。
Cornea. 1998 Mar;17(2):123-8. doi: 10.1097/00003226-199803000-00001.
Zotero 插件